RELAPSED LYMPHOMA

Clinical trials for RELAPSED LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new RELAPSED LYMPHOMA trials appear

Sign up with your email to follow new studies for RELAPSED LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug cocktail aims to wipe out stubborn lymphoma

Disease control Recruiting now

This study is testing whether a combination of three drugs—epcoritamab, zanubrutinib, and rituximab—is safe and effective for people whose follicular or marginal zone lymphoma has come back or hasn't responded to prior treatments. About 45 participants will receive the treatment …

Matched conditions: RELAPSED LYMPHOMA

Phase: PHASE2 • Sponsor: Reid Merryman, MD • Aim: Disease control

Last updated Mar 19, 2026 14:55 UTC

RELAPSED LYMPHOMA

Get alerted when new RELAPSED LYMPHOMA trials appear

New drug cocktail aims to wipe out stubborn lymphoma